Palisade Net Working Capital vs Retained Earnings Analysis
PALI Stock | USD 7.26 0.18 2.54% |
Palisade Bio financial indicator trend analysis is much more than just breaking down Palisade Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Palisade Bio is a good investment. Please check the relationship between Palisade Bio Net Working Capital and its Retained Earnings accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
Net Working Capital vs Retained Earnings
Net Working Capital vs Retained Earnings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Palisade Bio Net Working Capital account and Retained Earnings. At this time, the significance of the direction appears to have very week relationship.
The correlation between Palisade Bio's Net Working Capital and Retained Earnings is 0.27. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Palisade Bio, assuming nothing else is changed. The correlation between historical values of Palisade Bio's Net Working Capital and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Palisade Bio are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Net Working Capital i.e., Palisade Bio's Net Working Capital and Retained Earnings go up and down completely randomly.
Correlation Coefficient | 0.27 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Net Working Capital
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most indicators from Palisade Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Palisade Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.As of now, Palisade Bio's Enterprise Value Over EBITDA is increasing as compared to previous years. The Palisade Bio's current Enterprise Value Multiple is estimated to increase to 0.46, while Enterprise Value is projected to decrease to (8.9 M).
2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 2K | 4K | 3.3K | Cost Of Revenue | 168K | 192.1K | 176.4K |
Palisade Bio fundamental ratios Correlations
Click cells to compare fundamentals
Palisade Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Palisade Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.6M | 3.0M | 12.5M | 15.8M | 14.1M | 12.3M | |
Other Current Liab | 368.0K | 3.3M | 779K | 991K | 891.9K | 983.6K | |
Total Current Liabilities | 1.2M | 8.1M | 2.5M | 3.0M | 2.6M | 3.4M | |
Total Stockholder Equity | 5.1M | (16.6M) | 7.4M | 12.5M | 11.3M | 6.2M | |
Property Plant And Equipment Net | 242.7K | 280K | 112K | 310K | 208K | 233.1K | |
Net Debt | (4.9M) | 708K | (10.3M) | (12.0M) | (10.8M) | (10.2M) | |
Retained Earnings | (222.0M) | (68.0M) | (94.6M) | (109.2M) | (121.5M) | (127.6M) | |
Accounts Payable | 824.4K | 3.6M | 1.5M | 1.8M | 864K | 1.6M | |
Cash | 5.1M | 713K | 10.5M | 12.4M | 12.4M | 8.5M | |
Non Current Assets Total | 937.0K | 2.1M | 138K | 1.0M | 724K | 1.1M | |
Non Currrent Assets Other | 25.3K | 1.8M | 26K | 694K | 38K | 36.1K | |
Cash And Short Term Investments | 5.1M | 713K | 10.5M | 12.4M | 14.2M | 10.3M | |
Common Stock Total Equity | 151.6K | 182.1K | 38.7K | 173.0K | 155.7K | 147.9K | |
Common Stock Shares Outstanding | 7.3K | 55.5K | 187.0K | 880.3K | 9.3M | 9.7M | |
Liabilities And Stockholders Equity | 6.6M | 3.0M | 12.5M | 15.8M | 18.1M | 12.2M | |
Non Current Liabilities Total | 233.1K | 11.5M | 2.7M | 272K | 153K | 145.4K | |
Other Current Assets | 510.9K | 2.4M | 1.9M | 2.4M | 2.7M | 2.8M | |
Other Stockholder Equity | 227.1M | 51.4M | 101.9M | 121.6M | 139.9M | 139.3M | |
Total Liab | 1.5M | 19.6M | 5.1M | 3.3M | 2.7M | 2.6M | |
Property Plant And Equipment Gross | 268.1K | 10.8K | 112K | 310K | 208K | 218.2K | |
Total Current Assets | 5.6M | 896K | 12.4M | 14.7M | 13.3M | 11.2M | |
Accumulated Other Comprehensive Income | (821.9K) | (902.3K) | (6.2K) | (734.0) | (660.6) | (693.63) | |
Intangible Assets | 883.5K | 763.5K | 668.9K | 147.1K | 169.2K | 160.7K | |
Common Stock | 38.7K | 28K | 143K | 30K | 27K | 25.7K | |
Net Receivables | 21.1K | 59K | 150K | 1.4M | 1.7M | 1.7M | |
Other Assets | 13.9K | 24.0K | 26K | 157.6K | 29.9K | 48.2K | |
Capital Surpluse | 217.1M | 219.5M | 227.1M | 247.8M | 285.0M | 245.4M | |
Property Plant Equipment | 5K | 420K | 280K | 112K | 100.8K | 167.9K |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Palisade Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.00) | Revenue Per Share 0.548 | Return On Assets (0.54) | Return On Equity (1.03) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.